BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31849528)

  • 21. Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer.
    Li L; Zhang GQ; Chen H; Zhao ZJ; Chen HZ; Liu H; Wang G; Jia YH; Pan SH; Kong R; Wang YW; Sun B
    Oncotarget; 2016 Nov; 7(44):71773-71781. PubMed ID: 27708234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long intragenic non-coding RNA p53-induced transcript (LINC-PINT) as a novel prognosis indicator and therapeutic target in cancer.
    He T; Yuan C; Zhao C
    Biomed Pharmacother; 2021 Nov; 143():112127. PubMed ID: 34474342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Long Non-Coding RNA (LncRNA) LINC-PINT Downregulation in Cardiomyopathy and Retinopathy Progression Among Patients with Type 2 Diabetes.
    Zha T; Su F; Liu X; Yang C; Liu L
    Med Sci Monit; 2019 Nov; 25():8509-8514. PubMed ID: 31711064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) regulates the proliferation of human periodontal ligament stem cells and toll-like receptor 4 (TLR4) expression to improve periodontitis.
    Liu W; Zheng Y; Chen B; Ke T; Shi Z
    BMC Oral Health; 2019 Jun; 19(1):108. PubMed ID: 31196168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications of lncRNA LINC-PINT in cancer.
    Bukhari I; Khan MR; Li F; Swiatczak B; Thorne RF; Zheng P; Mi Y
    Front Mol Biosci; 2023; 10():1097694. PubMed ID: 37006616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linc-pint inhibits early stage pancreatic ductal adenocarcinoma growth through TGF-β pathway activation.
    Lu H; Yang D; Zhang L; Lu S; Ye J; Li M; Hu W
    Oncol Lett; 2019 May; 17(5):4633-4639. PubMed ID: 30944652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human lncRNA LINC-PINT inhibits tumor cell invasion through a highly conserved sequence element.
    Marín-Béjar O; Mas AM; González J; Martinez D; Athie A; Morales X; Galduroz M; Raimondi I; Grossi E; Guo S; Rouzaut A; Ulitsky I; Huarte M
    Genome Biol; 2017 Oct; 18(1):202. PubMed ID: 29078818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of long non-coding RNA LINC-PINT serves as a diagnostic and prognostic biomarker in patients with non-small cell lung cancer.
    Zhang C; Gong C; Li J; Tang J
    Oncol Lett; 2021 Mar; 21(3):210. PubMed ID: 33552292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [LncRNA LINC-PINT regulating proliferation and apoptosis of osteosarcoma cells by targeting miR-524-5p].
    Yang H; Cao C; Wang LJ
    Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):325-330. PubMed ID: 32375449
    [No Abstract]   [Full Text] [Related]  

  • 31. Long Non-coding RNA LINC-PINT Suppresses Cell Proliferation and Migration of Melanoma via Recruiting EZH2.
    Xu Y; Wang H; Li F; Heindl LM; He X; Yu J; Yang J; Ge S; Ruan J; Jia R; Fan X
    Front Cell Dev Biol; 2019; 7():350. PubMed ID: 31921860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long noncoding RNA LINC-PINT inhibits non-small cell lung cancer progression through sponging miR-218-5p/PDCD4.
    Zhang L; Hu J; Li J; Yang Q; Hao M; Bu L
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1595-1602. PubMed ID: 31010333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA PTCSC3 inhibits cell proliferation in laryngeal squamous cell carcinoma by down-regulating lncRNA HOTAIR.
    Xiao D; Cui X; Wang X
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31171714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long Noncoding RNA LINC-PINT Suppresses Cell Proliferation, Invasion, and EMT by Blocking Wnt/β-Catenin Signaling in Glioblastoma.
    Zhu H; Chen Z; Shen L; Tang T; Yang M; Zheng X
    Front Pharmacol; 2020; 11():586653. PubMed ID: 33505307
    [No Abstract]   [Full Text] [Related]  

  • 35. Long noncoding RNA
    Duan J; Ma X; Shi J; Xuan Y; Wang H; Li P; Zhang Y; Fan Y; Gong H; Ma X; Pang Y; Wang L; Yan Y; Zhang X
    Onco Targets Ther; 2019; 12():4729-4740. PubMed ID: 31417274
    [No Abstract]   [Full Text] [Related]  

  • 36. LncRNA PTCSC3 is upregulated in osteoporosis and negatively regulates osteoblast apoptosis.
    Liu X; Chen M; Liu Q; Li G; Yang P; Zhang G
    BMC Med Genomics; 2022 Mar; 15(1):57. PubMed ID: 35296322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA LINC-PINT attenuates paclitaxel resistance in triple-negative breast cancer cells via targeting the RNA-binding protein NONO.
    Chen J; Zhu M; Zou L; Xia J; Huang J; Deng Q; Xu R
    Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):801-809. PubMed ID: 32632453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Long Noncoding RNA Linc-Pint by Hepatitis C Virus in Infected Hepatocytes Enhances Lipogenesis.
    Khatun M; Sur S; Steele R; Ray R; Ray RB
    Hepatology; 2021 Jul; 74(1):41-54. PubMed ID: 33236406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deregulation of
    Garitano-Trojaola A; José-Enériz ES; Ezponda T; Unfried JP; Carrasco-León A; Razquin N; Barriocanal M; Vilas-Zornoza A; Sangro B; Segura V; Prósper F; Fortes P; Agirre X
    Oncotarget; 2018 Feb; 9(16):12842-12852. PubMed ID: 29560114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PINTology: A short history of the lncRNA LINC-PINT in different diseases.
    Bukhari I; Khan MR; Hussain MA; Thorne RF; Yu Y; Zhang B; Zheng P; Mi Y
    Wiley Interdiscip Rev RNA; 2022 Jul; 13(4):e1705. PubMed ID: 35019222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.